Evans M, Hicks D, Patel D, Patel V, McEwan P, Dashora U (2020) Optimising the benefits of SGLT2 inhibitors for type 1 diabetes
Seniors experienced similar cardiovascular benefits, with 32% reduction in major adverse events during extended follow-up studies
What To Do If You Experience Hair Loss From Ozempic Hair loss is a complicated issue, and while there are effective solutions, they require time and consistency
GLP-1 coverage cuts: What shifting payer policies mean for prescribing, access, and utilization Feb 18th, 2026 Glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide (sold under brandnames Wegovy and Ozempic) and tirzepatide (Zepbound, Mounjaro) have transformed how physicians and patients approach treatment for type 2 diabetes and obesity